Chris Benko

Healthcare Entrepreneurship 2024 Year-In-Review: Squid Game? My latest in @Forbes. forbes.com/sites/sachinja…

Why Election Day is a Koneksa Holiday with Kelly Alfaro @Koneksa linkedin.com/posts/cbenko_k…

Composability is also key for digital biomarkers design -- choosing which hardware, operating systems, signal processing & algorithms you need Today, @GoHumanFirst's @cesassano dropped a landscape map of the 600+ developers of biomarker components medium.com/elektra-labs/c…

Learn how #CovariateAdjustment can improve clinical trials by increasing statistical power & widening eligibility criteria. Join us on June 14 for a live webinar w key opinion leaders from @OwkinScience, @bmsnews & @ASCOCancerLinQ. Register to attend at bit.ly/3MdMTGy

"Vaccines don't stop transmission" is a popular argument against vaccine requirements. While vaccines aren't perfect (nothing is), they *do* reduce transmission, and that makes any environment safer. @Craig_A_Spencer does a great job of explaining how. theatlantic.com/ideas/archive/…

@sacjai The latter are almost exclusively in industry esp for vaccines. These capabilities are hard to develop/maintain, arguably why the top pharma orgs by R&D spend have ~100 year old roots. Interesting analysis doi.org/10.1073/pnas.1… @Dereklowe @ldtimmerman @DShaywitz

@sacjai Tremendous conflation btwn basic R that produce mostly pubs v translational/clinical Dev. Basic R is foundational doesn’t deliver drug candidates. Translational/clinical dev requires not only capital but focused capabilities: people, processes, technologies and aligned incentives

Sincere inquiry: There has been a glib, persistent anti-biopharma narrative that I first heard applied today to the covid vaccine. “The NIH developed the science and biopharma commercializes it.” The implication: biopharma development is easy/free-riding. (1/2)

Excited to share that HumanFirst (@GoHumanFirst) raised our Series A. Since launch, 22 of the top 25 pharma companies have used our Atlas to support decentralized trials. And virtual care is rapidly accelerating. Healthcare is coming home. wsj.com/articles/human…

Our latest e-book, brought to you by @koneksa, brings you an inside look into the rapidly evolving remote patient monitoring field. Download here: buff.ly/3s47t2h

Can sponsors generate reusable #clinicaltrials data assets? Develop a future-proof raw data roadmap for #wearables and digital measures with @Koneksa in an upcoming @actigraph webinar. Learn more and register today: hubs.ly/H0KtBNy0

Essentially, digital/data champions have been pushing for pharma to embrace digital/data tech, pharma orgs (typically, characteristically) respond conservatively, suspicious of latest shiny object. So far, in terms of actual impact, they are largely right (if also contributors).

The Challenge of Conducting Placebo-Controlled Trials as COVID-19 Vaccines Become Authorized ja.ma/2Zs3SPB via @JAMA_current part of @JAMANetwork great piece on why these vax went fast & the implications of unblinding & uneven vaccination on LT data and next gen vax dev

"Support regulatory science efforts to develop methodology for the evaluation and improvement of machine learning algorithms, including for the identification and elimination of bias, and for the evaluation and promotion of algorithm robustness." fda.gov/media/145022/d…

The @Koneksa snowman looks good, but we are concerned about the last 24 hours of activity monitoring data - body temperature readings are very low!

So true

We are proud to be sponsoring the first annual Women in Biopharma event hosted by @endpts. The event celebrates 20 extraordinary women who are advancing drug research & development. Want to attend? There's still time to register for tomorrow’s event: hubs.ly/H0CftV50

It’s been a big year for Koneksa. We’ve helped our partners develop and implement #digitalbiomarkers in #clinicaltrials, and now we have a new look. Visit the new hubs.ly/H0BMJH40 to see our new branding and learn how we can support your digital biomarker journey.

The Vaccine News is Good. But Let's the Keep the Masks for Now. By Larry Corey of @fredhutch, a leader of the COVID-19 vaccine trials. timmermanreport.com/2020/11/the-mr…

Explore the use of #spirometry in airway disease research at our upcoming webinar. Review challenges, benefits, and new published data on at-home vs. in-clinic spirometry and implications for #clinicaltrials. Register: hubs.ly/H0zC8kg0

Next up: Many of the teammates who developed 𝑇ℎ𝑒 𝑃𝑙𝑎𝑦𝑏𝑜𝑜𝑘 are going live at @CNSSummit right now! Join us & and you can download the guide here: playbook.dimesociety.org